Heparin-induced thrombocytopenia with thrombotic complications during prophylactic treatment with low-molecular-weight heparin

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 8, 1996, Pages 786-788

  De Raucourt, E ^a   Vinsonneau, C ^a   Juvin, K ^a   Fischer, A M ^a   Meyer, G ^a  

^a Hopital Laennec   (France)

Author keywords

Heparin induced thrombocytopenia; LMWH; Low molecular weight heparin

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; NICARDIPINE; PEFLOXACIN; TELDEPARIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0030461947     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199611000-00007     Document Type: Article

References (17)

1. Kelton JG, Smith JW, Warkentin TE, Hayward CPM, Denomme GA, Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994; 83: 3232-3239.
2. Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of multimolecular PF4-heparin complex as the major antigen. Thromb Haemostasis 1994; 71: 247-251.
3. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335.
4. Colwell CW, Spiro TE, Trowbridge AA, Stephens JWG, Gardiner Jr GA, Ritter MA. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Clin Orthop Rel Res 1995; 321: 19-27.
5. Gazzaniga GM, Angelini G, Pastorino G, Santoro E, Lucchini M, Dal Prà MLA. Enoxaparin in the prevention of deep venous thrombosis after major surgery: multricentric study. Int Surg 1993; 78: 271-275.
6. Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341: 259-265.
7. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993; 69: 344-350.
8. Hull R, Raskob G, Pineo G, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329: 1370-1376.
9. Eichinger S, Kyrle PA, Brenner B, et al. Thrombocytopenia associated with low-molecular-weight heparin. Lancet 1991; 337: 1425-1426.
10. Faivre R, Petiteau P, Kieffer Y. Low molecular weight heparin-induced thrombocytopenia complicated by massive pulmonary embolism and acute myocardial infarction: a case report. Thromb Haemostasis 1993; 69: 1117 (abstract).
11. Lecompte T, Kai Luo S, Stieltjes N, Lecrubier C, Samama MM. Thrombocytopenia associated with low-molecular-weight heparin. Lancet 1991; 338: 1217.
12. Tardy B, Page Y, Tardy-Poncet B, Comtet C, Zeni F, Bertrand JC. Thrombopénie induite par une héparine de bas poids moléculaire. Thérapie 1990; 45: 453.
13. Chong BH. Heparin-induced thrombocytopenia. Aust NZ J Med 1992; 22: 145-152.
14. Bedock B, Ffrench P, Blanc PL, Madignier S, Jay S. Thrombopénie sévère apparue sous traitement par la teldeparine. Press Méd 1990; 19: 720.
15. Ball A, L'Huillier AM, Dreyfuss L, Porte JL, Barthel JC. Thrombopénie à la fraxiparine: une observation. Press Méd 1989; 18: 1254.
16. Watrisse C, Lecoutre D, Groux-Pante C. Thrombopénie induite par une héparine de bas poids moléculaire. Cah Anesthesiol 1990; 38: 175-177.
17. Chin SP, Alvado G, Lemoine P. Thrombopénie induite par une héparine de bas poids moléculaire. Ann Fr Anesth Réanim 1992; 11: 587-591.